Anti-HRSV Fusion Glycoprotein Reference Antibody (RSV-002, RUO) (VK421296)

Name: Anti-HRSV Fusion Glycoprotein Reference Antibody (RSV-002, RUO)
Brand: abinScience
SKU: VK421296
Price: 370 USD
Availability: InStock

Datasheet Compartir producto Copiar información

Precio(USD):

Especificación:

100ug
1mg
5mg
10mg
25mg
50mg
100mg

Número:

Contáctenos

Vista general
Imágenes
Referencias
Datasheet
SDS

Vista general

Número de catálogo	VK421296
Descripción	Anti-HRSV F/Fusion glycoprotein F0 Antibody (RSV-002) (VK421296) is a research-grade recombinant antibody targeting F. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especies	Human respiratory syncytial virus A (HRSV-A)
Aplicaciones	ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Especie huésped	Human
Clonalidad	Monoclonal
Isotipo	IgG1
ID de clon	RSV-002
Objetivo	F, F1, F2, Fusion glycoprotein F0, Fusion glycoprotein F1, Fusion glycoprotein F2, Intervening segment, Pep27, Peptide 27, p27
Nivel de endotoxinas	< 10 EU/mg
Pureza	>95% as determined by SDS-PAGE.
Purificación	Protein A/G purified from cell culture supernatant.
Número de acceso	P03420, P11209, 12568, O36634, P13843
Forma	Liquid
Buffer de almacenamiento	0.01M PBS pH 7.4. Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.
Estabilidad y almacenamiento	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Nombres alternativos	BPM-RSV-002, BPM-RSV002, BPM-RSV002, RSV-002, RSV002, RSV002
Fondo	Fusion glycoprotein F0 is a ~63 kDa protein. Inactive precursor that is cleaved at two sites by a furin-like protease to give rise to the mature F1 and F2 fusion glycoproteins.
Nota	For research use only. Not suitable for clinical or therapeutic use.